NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMS+) Q2 2022 Earnings

11AugExpected
Q3 2021
Q4 2021
Q1 2022
Q2 2022
-0.07
-0.01
0.04
0.1

Details

Expected EPS
N/A
Actual EPS
-0.07
Surprise EPS
-0.07
Surprise Percent
+∞%

Description

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMS+) has reported earnings of -0.07 per share for Q2 2022.

0 Comments

Share your thoughts